{
 "PrintNo":"S6758","Session":2025,"Chamber":"SENATE","BillType":"Senate","Published":"2025-03-24T09:55:03.738408Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2025-03-24","Committee":"Health"}],
 "Actions":[{"Text":"REFERRED TO HEALTH","Date":"2025-03-24","Chamber":"SENATE"}],
 "Sponsors":[{"ID":1520,"Name":"Nathalia Fernandez","Short":"FERNANDEZ"}],
 "Title":"Requires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic",
 "Summary":"Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.",
 "LawSection":"Public Health Law","LawCode":"Amd §§3331 & 3309, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to requiring practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic"
}